Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2012
08/01/2012CN102614301A Combination for treating bone disease and preparing method
08/01/2012CN102614299A Traditional Chinese medicine for curing cancer pain
08/01/2012CN102614287A Film-spraying agent for treating acute soft tissue injuries
08/01/2012CN102614265A Swelling-diminishing and pain-relieving self-emulsifying ointment
08/01/2012CN102614233A Manufacturing method of microcapsule
08/01/2012CN102614230A Medicinal composition for treating rheumatoid arthritis and preparation method and application thereof
08/01/2012CN102614217A Preparation for curing periodontal disease
08/01/2012CN102614213A Application of glycyrrhizic acid, glycyrrhetinic acid or salt thereof as well as gel composition and preparation method for gel composition
08/01/2012CN102614202A Mixture and liquid medicine or oral liquid for injection
08/01/2012CN102614182A Solid preparation of compound ammonia phenol renin medicine composition liposome
08/01/2012CN102614177A Application of rupatadine to preparation of medicinal compositions for treating chronic obstructive pulmonary disease
08/01/2012CN102614156A Medical application of in-vivo metabolite of paeonol
08/01/2012CN102614149A Method for preparing sinomenine capsules
08/01/2012CN102614125A SapC-phosphatide nano vesicle freezed-drying preparation, and preparation method and application thereof
08/01/2012CN102614122A Ketorolac tromethamine nasal cavity spraying agent and preparation method thereof
08/01/2012CN102614120A Preparation method for sinomenine hydrochloride eye drops
08/01/2012CN102614119A Method for sinomenine hydrochloride injection by using non-organic solvent
08/01/2012CN102614115A Sodium dichlorophenolate self-emulsifying ointment
08/01/2012CN102614044A Hot compress bag for treating scapulohumeral periarthritis
08/01/2012CN102613356A Aquilaria agallocha leaf tea, as well as preparation and application thereof
08/01/2012CN102247557B Medicinal liquor used for preventing limb meridian diseases
08/01/2012CN102198132B Solid preparation of pharmaceutical composition of ketoprofen and omeprazole
08/01/2012CN102188568B Externally applied traditional Chinese medicine powder for treating cold
08/01/2012CN101743963B Mosquito repellent and preparation method thereof
08/01/2012CN101507758B Traditional Chinese medicine combination
08/01/2012CN101475505B Process for preparing mefenamic acid
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232264 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers
07/31/2012US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders
07/31/2012US8231898 Controlled release hydrocodone formulations
07/31/2012CA2525328C Novel phosphotetrahydropyrans and methods
07/31/2012CA2517491C Injectable liquid formulation of paracetamol
07/31/2012CA2503445C Methylene urea derivatives as raf-kinase inhibitors
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/31/2012CA2465375C 2-aryl-propionic acids and pharmaceutical compositions containing them
07/31/2012CA2404688C Nuclear factor .kappa.b inducing factor
07/31/2012CA2223402C Methods of inhibiting phagocytosis
07/26/2012WO2012099871A1 Modulation of lrch4 activity and therapeutic application thereof
07/26/2012WO2012099479A1 Injectable compositions for mastitis comprising an nsaid and an antibiotic in a non-aqueous solvent
07/26/2012WO2012099447A2 Transgenic pig expressing stnfr1-fc genes and the use thereof
07/26/2012WO2012099224A1 Extract of aquatic animal cartilage
07/26/2012WO2012099200A1 Pyrazole derivative
07/26/2012WO2012099142A1 Bromfenac aqueous liquid composition having preservative efficiency
07/26/2012WO2012098692A1 Composition for inhibiting target gene expression
07/26/2012WO2012098237A1 Compounds with super-aspirin effects
07/26/2012WO2012066488A3 Bridged spiro[2.4]heptane ester derivatives
07/26/2012WO2012034039A3 Anti-il-1 beta antibodies and methods of use
07/26/2012US20120190832 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
07/26/2012US20120190821 Recombinant soluble fc receptors
07/26/2012US20120190753 Compositions Containing Aromatic Aldehydes and Their Use in Treatments
07/26/2012US20120190751 Compounds for treatments of inflammation
07/26/2012US20120190750 Stable ready to use injectable paracetamol formulation
07/26/2012US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/26/2012US20120190731 Methods and compositions to reduce oxidative stress
07/26/2012US20120190730 Targeting cells with altered microrna expression
07/26/2012US20120190722 Ketorolac tromethamine compositions for treating or preventing ocular pain
07/26/2012US20120190706 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
07/26/2012US20120190703 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190698 Methods of predicting thiopurine response
07/26/2012US20120190695 Phenyloxadiazole derivatives as pgds inhibitors
07/26/2012US20120190692 Selective substituted pyridine ligands for neuronal nicotinic receptors
07/26/2012US20120190691 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
07/26/2012US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/26/2012US20120190674 Sulfonamides as trpm8 modulators
07/26/2012US20120190669 Oxindole compounds
07/26/2012US20120190665 Pyrazolopyrimidine jak inhibitor compounds and methods
07/26/2012US20120190663 Use of free dna as an early predictor of severity in acute pancreatitis
07/26/2012US20120190661 Androgen composition for treating an opthalmic condition
07/26/2012US20120190658 Method And Composition For The Treatment Of Adverse Skin Conditions
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120190650 Inhibitors of Autotaxin
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190632 Anti-bacterial infection, inflammation, and leukemia composition and use thereof
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120189724 Polyphenol-containing composition for oral administration or external use and use of same
07/26/2012US20120189716 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
07/26/2012US20120189714 Compositions including beta-hydroxy-beta-methylbutyrate
07/26/2012US20120189713 Monomers and phase-separated biocompatible polymer compositions prepared therefrom for medical uses
07/26/2012US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189690 Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein
07/26/2012US20120189689 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
07/26/2012US20120189685 Wound dressing comprising an anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group iv of the periodic system of elements
07/26/2012US20120189684 Skincare Compositions
07/26/2012US20120189679 Method for coating powders
07/26/2012US20120189674 Compositions for topical delivery of the pharmacologically active compounds
07/26/2012US20120189673 Polypeptides and uses thereof
07/26/2012US20120189672 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
07/26/2012US20120189669 Solid Forms for Tissue Repair
07/26/2012US20120189667 Method for repairing or replacing damaged tissue
07/26/2012US20120189651 Active agent complex and formulation comprising the active agent complex
07/26/2012US20120189643 Toll Like Receptor 3 Antagonists, Methods and Uses
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189633 Anti-kit antibodies and uses thereof
07/26/2012US20120189628 Anti-il-tif antibodies and methods of using in inflammation
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1272